4/A
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-011781
Chief Financial Officer acquired 19,482 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2022-01-06 | Conversion | +19,482 | 19,482 | I | ||
| Derivatives | |||||||
| FRATES JAMES M Chief Financial Officer | 2022-01-06 | Conversion · Series C-1 Preferred Stock | −19,482 | 0 | I | ||
Loading xslF345X04/doc4a.xml…